PL3634415T3 - Kompozycje okulistyczne zawierające brymonidynę i ketotifen do zastosowania w leczeniu alergii - Google Patents
Kompozycje okulistyczne zawierające brymonidynę i ketotifen do zastosowania w leczeniu alergiiInfo
- Publication number
- PL3634415T3 PL3634415T3 PL18813969.5T PL18813969T PL3634415T3 PL 3634415 T3 PL3634415 T3 PL 3634415T3 PL 18813969 T PL18813969 T PL 18813969T PL 3634415 T3 PL3634415 T3 PL 3634415T3
- Authority
- PL
- Poland
- Prior art keywords
- ketotifen
- allergy
- treatment
- compositions containing
- containing brimonidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762516931P | 2017-06-08 | 2017-06-08 | |
| US201862621082P | 2018-01-24 | 2018-01-24 | |
| PCT/US2018/036440 WO2018226942A1 (en) | 2017-06-08 | 2018-06-07 | Low-dose brimonidine combinations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3634415T3 true PL3634415T3 (pl) | 2026-04-07 |
Family
ID=64562826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18813969.5T PL3634415T3 (pl) | 2017-06-08 | 2018-06-07 | Kompozycje okulistyczne zawierające brymonidynę i ketotifen do zastosowania w leczeniu alergii |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20180353504A1 (pl) |
| EP (2) | EP3634415B1 (pl) |
| JP (3) | JP2020523312A (pl) |
| KR (2) | KR20240090655A (pl) |
| CN (2) | CN117122600A (pl) |
| AU (2) | AU2018279074B2 (pl) |
| CA (1) | CA3066398A1 (pl) |
| CL (3) | CL2019003572A1 (pl) |
| DK (1) | DK3634415T3 (pl) |
| ES (1) | ES3064032T3 (pl) |
| FI (1) | FI3634415T3 (pl) |
| LT (1) | LT3634415T (pl) |
| MX (3) | MX2019014748A (pl) |
| MY (1) | MY205909A (pl) |
| NZ (1) | NZ760151A (pl) |
| PL (1) | PL3634415T3 (pl) |
| PT (1) | PT3634415T (pl) |
| RS (1) | RS67824B1 (pl) |
| SG (1) | SG11201911750RA (pl) |
| WO (2) | WO2018226942A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3817751T3 (pl) | 2018-07-03 | 2025-09-08 | Fennec Pharmaceuticals, Inc. | Postacie użytkowe bezwodnego tiosiarczanu sodu |
| UA129938C2 (uk) * | 2020-04-29 | 2025-09-17 | Сентісс Фарма Прайвет Лімітед | Офтальмологічні композиції, що містять комбінацію бринзоламіду та бримонідину |
| US20230201117A1 (en) * | 2020-05-27 | 2023-06-29 | Lupin Limited | Ophthalmic nanoemulsion compositions |
| JP2022075651A (ja) * | 2020-11-06 | 2022-05-18 | 千寿製薬株式会社 | 眼科用液体製剤 |
| KR102444571B1 (ko) * | 2020-11-18 | 2022-09-19 | 주식회사태준제약 | 세티리진 및 토코페솔란을 포함하는 안과용 조성물 |
| CN114796219B (zh) * | 2022-05-18 | 2024-08-20 | 沈阳药科大学 | 一种用于治疗青光眼的复方药物组合物及其用途 |
| WO2024028815A1 (en) * | 2022-08-04 | 2024-02-08 | Bausch + Lomb Ireland Limited | Ophthalmic composition comprising an anti-allergen and a redness reduction agent |
| CA3264067A1 (en) * | 2022-08-04 | 2024-02-08 | Bausch + Lomb Ireland Limited | OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS-REDUCING AGENT |
| CN120284871B (zh) * | 2025-05-09 | 2026-03-10 | 南京帝昌医药科技有限公司 | 用于鼻腔的含奥洛他定与溴莫尼定的复方制剂组合物及其制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7030149B2 (en) * | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| PT1534313E (pt) * | 2002-07-30 | 2013-01-25 | Omeros Corp | Soluções e método de irrigação oftalmológica |
| CN100463668C (zh) * | 2005-05-09 | 2009-02-25 | 凌沛学 | 可逆性热凝胶化水性药物组合物 |
| EP2471507B1 (en) * | 2006-09-29 | 2017-03-01 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices used in the treatment of ocular allergies |
| ITMI20070890A1 (it) * | 2007-05-04 | 2008-11-05 | Sifi Spa | Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma |
| WO2009084021A2 (en) * | 2007-10-16 | 2009-07-09 | Sun Pharma Advanced Research Company Limited | Novel ophthalmic compositions |
| US20100203165A1 (en) * | 2008-08-01 | 2010-08-12 | Gerald Horn | Compositions and methods for treatment of disorders or conditions of the eye |
| US20100028266A1 (en) * | 2008-08-01 | 2010-02-04 | Alpha Synergy Development. Inc. | Composition and methods for treating allergic response |
| US12246013B2 (en) * | 2008-08-01 | 2025-03-11 | Eye Therapies Llc | Vasoconstriction compositions and methods of use |
| AU2010226249A1 (en) * | 2009-03-17 | 2011-10-13 | Aciex Therapeutics, Inc. | Ophthalmic formulations of ketotifen and methods of use |
| CA2755679C (en) * | 2009-03-17 | 2017-09-12 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| MX2011013060A (es) * | 2009-06-05 | 2012-02-28 | Aciex Therapeutics Inc | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. |
| US8445526B2 (en) * | 2011-02-03 | 2013-05-21 | Glaucoma & Nasal Therapies Llc | Compositions and methods for treatment of glaucoma |
| MX346312B (es) * | 2011-04-05 | 2017-03-15 | Optosolve Res & Dev Ltd | Tratamientos oftalmicos. |
| US20130203813A1 (en) * | 2011-05-04 | 2013-08-08 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
| JP2014520895A (ja) * | 2011-07-20 | 2014-08-25 | アラーガン インコーポレイテッド | ビマトプロストおよびブリモニジンの固定用量の組み合わせ |
| US20140194527A1 (en) * | 2012-02-29 | 2014-07-10 | Rohto Usa, Inc. | Geranylgeranylacetone formulations and retinal delivery thereof |
| EP2841104A1 (en) * | 2012-04-24 | 2015-03-04 | Allergan, Inc. | Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use |
| US9833441B2 (en) * | 2013-08-28 | 2017-12-05 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9314427B2 (en) * | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
| WO2015138786A1 (en) * | 2014-03-12 | 2015-09-17 | The Trustees Of Columbia University In The City Of New York | Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking agents |
| US20180250313A1 (en) * | 2015-09-08 | 2018-09-06 | Viewpoint Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
| US9694003B2 (en) * | 2015-10-15 | 2017-07-04 | Bridge Pharma, Inc. | Formulations and methods for treating high intraocular pressure |
| US20200197398A1 (en) * | 2017-06-08 | 2020-06-25 | Eye Therapies, Llc | Netarsudil and low-dose brimonidine combination and uses thereof |
-
2018
- 2018-06-07 RS RS20260266A patent/RS67824B1/sr unknown
- 2018-06-07 SG SG11201911750RA patent/SG11201911750RA/en unknown
- 2018-06-07 CN CN202311102693.0A patent/CN117122600A/zh active Pending
- 2018-06-07 KR KR1020247016783A patent/KR20240090655A/ko active Pending
- 2018-06-07 EP EP18813969.5A patent/EP3634415B1/en active Active
- 2018-06-07 MX MX2019014748A patent/MX2019014748A/es unknown
- 2018-06-07 CN CN201880052027.1A patent/CN110996954A/zh active Pending
- 2018-06-07 EP EP25225699.5A patent/EP4691568A2/en active Pending
- 2018-06-07 PL PL18813969.5T patent/PL3634415T3/pl unknown
- 2018-06-07 PT PT188139695T patent/PT3634415T/pt unknown
- 2018-06-07 KR KR1020207000500A patent/KR20200018580A/ko not_active Ceased
- 2018-06-07 CA CA3066398A patent/CA3066398A1/en active Pending
- 2018-06-07 JP JP2019567535A patent/JP2020523312A/ja active Pending
- 2018-06-07 MY MYPI2019007233A patent/MY205909A/en unknown
- 2018-06-07 FI FIEP18813969.5T patent/FI3634415T3/fi active
- 2018-06-07 NZ NZ760151A patent/NZ760151A/en unknown
- 2018-06-07 ES ES18813969T patent/ES3064032T3/es active Active
- 2018-06-07 AU AU2018279074A patent/AU2018279074B2/en active Active
- 2018-06-07 LT LTEPPCT/US2018/036440T patent/LT3634415T/lt unknown
- 2018-06-07 DK DK18813969.5T patent/DK3634415T3/da active
- 2018-06-07 US US16/002,106 patent/US20180353504A1/en not_active Abandoned
- 2018-06-07 WO PCT/US2018/036440 patent/WO2018226942A1/en not_active Ceased
-
2019
- 2019-01-25 WO PCT/US2019/015141 patent/WO2019236148A1/en not_active Ceased
- 2019-12-06 MX MX2022008478A patent/MX2022008478A/es unknown
- 2019-12-06 MX MX2022008479A patent/MX2022008479A/es unknown
- 2019-12-06 CL CL2019003572A patent/CL2019003572A1/es unknown
-
2022
- 2022-03-21 US US17/699,405 patent/US20220233524A1/en active Pending
- 2022-09-21 CL CL2022002566A patent/CL2022002566A1/es unknown
- 2022-09-21 CL CL2022002564A patent/CL2022002564A1/es unknown
-
2023
- 2023-01-31 JP JP2023012550A patent/JP2023055823A/ja active Pending
- 2023-12-13 AU AU2023282222A patent/AU2023282222B2/en active Active
-
2024
- 2024-08-19 JP JP2024137601A patent/JP2024164101A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3634415T3 (pl) | Kompozycje okulistyczne zawierające brymonidynę i ketotifen do zastosowania w leczeniu alergii | |
| DK3377637T3 (da) | Sammensætninger til anvendelse i fremgangsmåder til behandling af sår, lidelser og sygdomme i huden | |
| IL254207B (en) | Oral care compositions and methods of use | |
| HUE052095T2 (hu) | Keratin kezelési készítmények és eljárások | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| IL280827A (en) | Integrin alpha 4 antagonists and compositions comprising same for use in treating ocular conditions | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| DK3160234T3 (da) | Sammensætning til anvendelse til forebyggelse og behandling af oftalmisk-, hånd- eller fodbiofilmvækst | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| PL3512517T3 (pl) | Stosowanie pridopidyny w leczeniu lęku i depresji | |
| PL3500287T3 (pl) | Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych | |
| CY1126258T1 (el) | Ενωσεις ινδολινονης και χρηση αυτων στη θεραπεια ινωτικων ασθενειων | |
| PL3229794T3 (pl) | Kombinacja farmaceutyczna obejmująca ponesimod i jej zastosowanie w leczeniu stwardnienia rozsianego | |
| IL271464A (en) | Nk-1 antagonist compositions and methods for use in treating depression | |
| EP3687491A4 (en) | HAIR CARE COMPOSITIONS AND METHODS | |
| PL3732294T3 (pl) | Tymohydrochinon do stosowania w leczeniu hiperglikemii | |
| IL270978B (en) | Grape skin for use in the treatment of dysbiosis | |
| PL3592355T3 (pl) | Kx2-391/kx-01 do zastosowania w leczeniu rogowacenia słonecznego | |
| IL251351A0 (en) | Preparations for use in the treatment and prevention of surgical infections | |
| EP3236992C0 (en) | PEPTIDES AND THEIR USE IN SKIN TREATMENT | |
| IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| EP3185862A4 (en) | PROTECTIVE METALLOTHIONEIN ANALOGUES, THEIR COMPOSITIONS AND THEIR USE IN THE TREATMENT OF PATHOGENIC DISEASES | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee |